146 related articles for article (PubMed ID: 25525139)
1. Analytical validation of a second-generation immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in canine blood.
Cahill RJ; Pigeon K; Strong-Townsend MI; Drexel JP; Clark GH; Buch JS
J Vet Diagn Invest; 2015 Jan; 27(1):61-7. PubMed ID: 25525139
[TBL] [Abstract][Full Text] [Related]
2. Analytical validation of an immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in feline blood.
Mainville CA; Clark GH; Esty KJ; Foster WM; Hanscom JL; Hebert KJ; Lyons HR
J Vet Diagn Invest; 2015 Jul; 27(4):414-21. PubMed ID: 26077545
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
[TBL] [Abstract][Full Text] [Related]
4. The effects of storage conditions on measurements of canine N-terminal pro-B-type natriuretic peptide.
Hezzell MJ; Boswood A; Lötter N; Elliott J
J Vet Cardiol; 2015 Mar; 17(1):34-41. PubMed ID: 25547663
[TBL] [Abstract][Full Text] [Related]
5. Analytical validation of a novel point-of-care immunoassay for canine N-terminal pro-brain natriuretic peptide analysis.
Harr KE; Gordon SG; Baumwart RD; Feldgreber R; Spiro MR
Vet Clin Pathol; 2022 Sep; 51(3):398-407. PubMed ID: 35312100
[TBL] [Abstract][Full Text] [Related]
6. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
Fox PR; Oyama MA; Hezzell MJ; Rush JE; Nguyenba TP; DeFrancesco TC; Lehmkuhl LB; Kellihan HB; Bulmer B; Gordon SG; Cunningham SM; MacGregor J; Stepien RL; Lefbom B; Adin D; Lamb K
J Vet Intern Med; 2015 Jan; 29(1):171-9. PubMed ID: 25308881
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.
Hezzell MJ; Rush JE; Humm K; Rozanski EA; Sargent J; Connolly DJ; Boswood A; Oyama MA
J Vet Intern Med; 2016; 30(2):536-42. PubMed ID: 26813037
[TBL] [Abstract][Full Text] [Related]
8. The use of NT-proBNP assay in the management of canine patients with heart disease.
Oyama MA; Singletary GE
Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):545-58. PubMed ID: 20610010
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
10. Effects of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease.
Collins SA; Patteson MW; Connolly DJ; Brodbelt DC; Torrance AG; Harris JD
J Vet Cardiol; 2010 Apr; 12(1):41-8. PubMed ID: 20226751
[TBL] [Abstract][Full Text] [Related]
11. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
Couto KM; Iazbik MC; Marín LM; Zaldivar-López S; Beal MJ; Gómez Ochoa P; Couto CG
Vet Clin Pathol; 2015 Sep; 44(3):405-9. PubMed ID: 25982692
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
Oyama MA; Fox PR; Rush JE; Rozanski EA; Lesser M
J Am Vet Med Assoc; 2008 May; 232(10):1496-503. PubMed ID: 18479239
[TBL] [Abstract][Full Text] [Related]
14. Detection by ELISA of C-terminal proBNP in plasma from cats with cardiomyopathy.
Solter PF; Oyama MA; Machen MC; Trafny DJ; Sisson DD
Vet J; 2015 Nov; 206(2):213-7. PubMed ID: 26324638
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
Wurtinger G; Henrich E; Hildebrandt N; Wiedemann N; Schneider M; Hassdenteufel E
BMC Vet Res; 2017 Dec; 13(1):394. PubMed ID: 29262821
[TBL] [Abstract][Full Text] [Related]
16. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
[TBL] [Abstract][Full Text] [Related]
17. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
Wolf J; Gerlach N; Weber K; Klima A; Wess G
Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
Oyama MA; Rush JE; Rozanski EA; Fox PR; Reynolds CA; Gordon SG; Bulmer BJ; Lefbom BK; Brown BA; Lehmkuhl LB; Prosek R; Lesser MB; Kraus MS; Bossbaly MJ; Rapoport GS; Boileau JS
J Am Vet Med Assoc; 2009 Dec; 235(11):1319-25. PubMed ID: 19951101
[TBL] [Abstract][Full Text] [Related]
20. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood.
Zugck C; Nelles M; Katus HA; Collinson PO; Gaze DC; Dikkeschei B; Gurr E; Hayen W; Haass M; Hechler C; van Hoof V; Guerti K; van Waes C; Printzen G; Klopprogge K; Schulz I; Zerback R
Clin Chem Lab Med; 2006; 44(10):1269-77. PubMed ID: 17032141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
